Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. SPY
6. GOOGL
7. USO
8. MMED
9. CRDO
10. GOOG

Go back to Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212
(NASDAQ: RLYB) Delayed: 17.13 +0.44 (2.64%)
Previous Close $16.69    52 Week High $ 
Open $16.65    52 Week Low $ 
Day High $17.26    P/E N/A 
Day Low $16.65    EPS $ 
Volume 22,787